Skip to main content
Jennifer Lue, MD, Oncology, Commack, NY

JenniferKimberlyLueMD

Oncology Commack, NY

Hematologic Oncology

Assistant Member Lymphoma Service Department of Medicine Memorial Sloan Kettering Cancer Center

Overview of Dr. Lue

Dr. Jennifer Lue is an oncologist in Commack, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from New York University Grossman School of Medicine and has been in practice 6 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 20 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2014 - 2017
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2011 - 2014
  • New York University School of Medicine
    New York University School of MedicineClass of 2011

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2013 - 2026
  • CT State Medical License
    CT State Medical License 2023 - 2025
  • NJ State Medical License
    NJ State Medical License 2023 - 2025
  • PA State Medical License
    PA State Medical License 2023 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Cell of Origin and Treatment Impact on the Outcome of Monomorphic Post-Transplant Lymphoproliferative Disorder-Diffuse Large B-Cell Lymphoma Subtype
    Jennifer Kimberly Lue, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • A basal gene expression signature to predict for synergy of combined EZH2 and HDAC inhibition in EZH2 dysregulated lymphomas. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Committees

  • Member, Protocol Review and Monitoring Committee 2018 - Present